THOMAS MARWICK, MBBS, PhD, MPH
Tom Marwick is the Director of Baker Heart and Diabetes Institute.
His education was completed at University of Melbourne, Australia; University of Louvain, Belgium and Harvard.
His main contribution are in clinical research and research training, and has supervised more than 30 research higher-degree students. He was one of the initiators of stress echocardiography, and has made contributions to the prognostic evidence underlying cardiovascular imaging.
His main research interests relate to detection of early cardiovascular disease and cost-effective application of cardiac imaging techniques for treatment. He has published over 650 papers, reviews, chapters and editorials, and is an Associate Editor at JACC and Deputy Editor at JACC-Cardiovascular Imaging.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease